Description

Dorecotuss Retard CAS NO 86585-86-6 is a specialized pharmaceutical intermediate or active ingredient known for its antitussive (cough suppressant) properties. It is valued for its controlled-release formulation, providing prolonged therapeutic effect and improved patient compliance. This compound is primarily required by pharmaceutical manufacturers and research institutions developing advanced respiratory and cough relief medications.

Application

• Pharmaceutical Active Ingredient: Core component in the formulation of extended-release cough suppressant and antitussive medications.
• Controlled-Release Drug Delivery: Used in the development of sustained-release oral dosage forms such as tablets and capsules.
• Respiratory Therapeutics: Key intermediate for synthesizing advanced compounds targeting chronic cough and upper respiratory conditions.
• Pharmaceutical Research & Development: Serves as a critical reference standard and building block in medicinal chemistry for new drug discovery.
• Generic Drug Manufacturing: Essential for producing generic versions of branded antitussive drugs with retard formulations.

Basic Information

Product Name	Dorecotuss Retard
CAS No.	86585-86-6
Molecular Formula	C22H30N2O2S
Molecular Weight	386.55 g/mol
Synonyms	Dropropizine; (-)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol; S(-)-Dropropizine; Levodropropizine; (-)-Dropropizine; S-(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; DF-526
EINECS	Contact for details

Quality Control

Our Dorecotuss Retard is manufactured under strict quality systems. Each batch undergoes comprehensive analytical testing to ensure it meets high-purity standards suitable for pharmaceutical use. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with every shipment to guarantee supply reliability and regulatory compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	98.0% - 102.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Impurity	≤ 0.5%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.